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Abstract
Genetic risk prediction is an important component of individualized medicine, but
prediction accuracies remain low for many complex diseases. A fundamental limitation
is the sample sizes of the studies on which the prediction algorithms are trained. One
way to increase the effective sample size is to integrate information from previously
existing studies. However, it can be difficult to find existing data that examine the
target disease of interest, especially if that disease is rare or poorly studied. Further-
more, individual-level genotype data from these auxiliary studies are typically difficult
to obtain. This paper proposes a new approach to integrative genetic risk prediction
of complex diseases with binary phenotypes. It accommodates possible heterogeneity
in the genetic etiologies of the target and auxiliary diseases using a tuning parameter-
free nonparametric empirical Bayes procedure, and can be trained using only auxiliary
summary statistics. Simulation studies show that the proposed method can provide
superior predictive accuracy relative to non-integrative as well as integrative classifiers.
The method is applied to a recent study of pediatric autoimmune diseases, where it
substantially reduces prediction error for certain target/auxiliary disease combinations.
The proposed method is implemented in the R package ssa.
1 Introduction
Genetic risk prediction for complex diseases is an important but difficult problem. Genome-
wide association studies (GWAS) have successfully identified many SNPs associated with
human disease, but it has been difficult to translate these successes into accurate risk pre-
diction models (Kraft and Hunter, 2009; Jostins and Barrett, 2011). The low accuracies can
in part be attributed to the fact that much of the heritability of a complex disease is likely
due to a large number of SNPs whose effect sizes are too weak to be discovered in any given
GWAS (Manolio et al., 2009; Chatterjee et al., 2013; Dudbridge, 2013).
To address this issue, recent research has focused on developing new prediction algorithms
that aggregate information over a large number of SNPs, rather than using only those that
reach genome-wide significance (Chatterjee et al., 2016). For example, polygenic risk scores
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can be constructed by taking weighted sums of all typed SNPs, or all SNPs that pass a
loose significance threshold. The weights can be calculated based on univariate regression
coefficients (Purcell et al., 2009; Chatterjee et al., 2013; Shi et al., 2016), with or without
accounting for linkage disequilibrium (Vilhja´lmsson et al., 2015; Mak et al., 2016), or by
using machine learning algorithms such as the lasso (Wei et al., 2013; Okser et al., 2014).
The weights can also be treated as random draws from some prior distribution, and risk
scores can be constructed using their posterior distributions (Zhou et al., 2013; Golan and
Rosset, 2014; Speed and Balding, 2014).
These new methods are still fundamentally limited by the sample sizes of the GWAS data
on which they are trained (Wray et al., 2013). A straightforward way to increase sample
size is to recruit additional study subjects, but this is time-consuming and costly. Instead,
the training data can be augmented with data from previously existing studies of the disease
of interest, for example by using meta-analytic methods (Stahl et al., 2012; Cross-Disorder
Group of the Psychiatric Genomics Consortium et al., 2013a,b; Shi and Lee, 2016). However,
this is only feasible when developing risk prediction models for well-studied diseases. For
other diseases, especially rare conditions, there may not be many existing GWAS studies,
and the ones that do exist may be so small that integrating them may not be very useful.
This paper studies an alternative method of increasing effective sample size: borrowing
information from auxiliary GWAS studies of diseases different from, but potentially related
to, the target disease of interest. For example, recent studies of co-heritability have uncovered
high degrees of genetic correlation between psychiatric disorders (Lee et al., 2012; Yang et al.,
2013) and between autoimmune diseases (Li et al., 2015a,b). Genetic correlation between
the target and auxiliary diseases implies that some of the SNPs that are predictive of one
will simultaneously be predictive of others. This dramatically enlarges the pool of existing
studies that can be leveraged to improve prediction accuracy for the target disease. A major
difficulty is that individual-level genotype data from existing studies are often difficult to
obtain due to privacy concerns, so prediction methods that can be trained using only GWAS
summary statistics are preferable.
So far, it appears that there exist very few methods capable of this type of integrative
genetic risk prediction. Given GWAS data for a target disease and auxiliary diseases, Li
et al. (2014) and Maier et al. (2015) posit linear models for the effects of the SNPs, so that
to each SNP there corresponds a vector of regression coefficients, one for each disease. They
then assume a multivariate prior distribution on these coefficients; the degree of correlation
between the coefficients quantifies the amount of information that can be borrowed across
diseases. However, they require parametric assumptions on the prior distribution as well as
selection or estimation of tuning parameters, e.g. those that govern the prior covariances
between the coefficients, which can be computationally intensive and inaccurate. Further-
more, their methods require raw genotype data. There do not appear to exist any genetic
risk prediction methods than can integrate only summary statistics from auxiliary GWAS.
This paper proposes a new approach to integrative genetic risk prediction of complex
diseases with binary phenotypes. It does not require raw genotype data from either the
disease of interest or the related diseases and can be trained using only summary statistics.
It also uses a tuning parameter-free nonparametric empirical Bayes procedure to estimate
prior distributions; this automatically learns the degree of genetic similarity between the
target and auxiliary diseases. The proposed method is computationally straightforward and
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is implemented in the R package ssa.
The remainder of this paper is organized as follows. Section 2 describes the proposed
method and Section 3 studies its performance in simulations and in a study of pediatric
autoimmune diseases, conducted by Hakonarson and colleagues at the Children’s Hospital of
Philadelphia (Li et al., 2015a,b). Section 4 concludes with a discussion of possible extensions
and future work.
2 Methods
2.1 Statistical formulation
Genetic risk prediction for binary disease phenotypes can be formulated as a classification
problem. For a new subject whose disease status Ynew ∈ {0, 1} is unobserved, let Xnew =
(Xnew,1, . . . , Xnew,d)
> be the observed genotypes of d SNPs, where Xnew,j is the number of
minor alleles of the jth SNP. The goal is to use Xnew to predict Ynew, where for example
Ynew = 0 means that the subject does not have the disease.
Let D = {(Xi, Yi), i = 1, . . . , n} denote the training data for the target disease, where
Xi = (Xi1, . . . , Xid)
> is the vector of genotypes of the ith subject, n0 and n1 are the numbers
of training subjects with Yi = 0 and Yi = 1, respectively, and n = n0 +n1. Also assume that
summary statistics from an auxiliary GWAS study of another disease, potentially related to
the one of interest, are available. Denote these statistics by T = (T1, . . . , Td)
>, where Tj is
the test statistic for the marginal association between the jth SNP and the auxiliary disease.
For clarity, it will be assumed that only a single auxiliary GWAS is used. It is conceptually
straightforward to extend the proposed method to multiple auxiliary GWAS results; this is
further discussed in Section 4.
The integrative genetic risk prediction problem is to develop a classifier
δ(Xnew;D,T) : Rd × (Rd × {0, 1})n × Rd → {0, 1},
trained using both D and T, that minimizes the misclassification rate
R(δ) = P{Ynew 6= δ(Xnew;D,T)}. (1)
This differs from the standard non-integrative risk prediction problem, where the classifier
δ is allowed to depend only on D and not on T.
Several assumptions are made throughout the remainder of this paper. First, the (Xi, Yi)
are assumed to be independent and identically distributed across all i = new, 1, . . . , n. Next,
all SNPs in Xi are assumed to be in linkage equilibrium. This can be approximately achieved
by using linkage disequilibrium (LD) pruning. There is evidence that pruning can improve
the accuracy of genetic risk prediction (Shi et al., 2016), and even if pruning is not done,
ignoring LD and treating SNPs as independent can still give accurate classification (Bickel
and Levina, 2004; Hand et al., 2006; Zhao et al., 2014). A complete treatment of classification
under LD is difficult and is left for future work.
Finally, all SNPs are assumed to be in Hardy-Weinberg equilibrium, so that for i =
new, 1, . . . , n,
Xij | Yi = y ∼ Bin(2, piyj), y ∈ {0, 1},
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where piyj is the minor allele frequency of the jth SNP in class y. Typed SNPs that are
not in Hardy-Weinberg equilibrium can be dropped from analysis. The auxiliary summary
statistics Tj are assumed to arise from chi-square statistics from an existing GWAS study
conducted on an independent sample of subjects, so the Tj are statistically independent of
(Xnew, Ynew) and D and follow
Tj ∼ χ21(λj).
SNPs that are not associated with the auxiliary disease will have λj = 0. Many common
association tests, such as the allelic test for association, give chi-square test statistics, and
the approach proposed below can be easily modified if the Tj are otherwise distributed.
2.2 Review of non-integrative classification
It is well-known (Devroye et al., 1996) that the optimal classifier that minimizes the mis-
classification rate R(δ) (1) is given by
δ?(Xnew;D,T) = I
{
P(Ynew = 1 | Xnew,D,T)
P(Ynew = 0 | Xnew,D,T) ≥ 1
}
.
Under the assumptions in Section 2.1, (Xnew, Ynew) is independent of D and T, so the optimal
classifier reduces to
δ?(Xnew;D,T) = I
{
log
P
1− P +
d∑
j=1
log
fBin(Xnew,j; 2, pi1j)
fBin(Xnew,j; 2, pi0j)
≥ 0
}
, (2)
where P = P(Ynew = 1) is the prevalence of the target disease of interest and fBin(x; 2, pi) is
the probability mass function of a Bin(2, pi) random variable.
The form of δ? (2) shows that optimal prediction of the target disease does not benefit
from integration of the T. This is one reason why standard methods for genetic risk pre-
diction do not consider auxiliary sources of information. Of course, optimal prediction also
does not benefit from the training data D either, because the optimal classifier uses the true
minor allele frequencies piyj. It makes sense that if the true piyj were known, both training
data and auxiliary GWAS summary statistics would be irrelevant for optimal prediction.
Clearly, the oracle δ? cannot be implemented in practice, since the piyj are unknown.
Instead, most existing classifiers calculate estimates of piyj using D, which are then plugged
into δ?. Using maximum likelihood estimates of piyj leads to the standard naive Bayes
classifier. However, since the total number of SNPs d is large, maximum likelihood estimation
of the high-dimensional vectors (piy1, . . . , piyd)
> for y ∈ {0, 1} can be inaccurate. A popular
alternative is to use some form of regularized estimation. A number of strategies for high-
dimensional discriminant analysis have been developed in this vein, though mostly under
the assumption that the Xij are normal rather than binomial random variables (Fan et al.,
2008; Greenshtein and Park, 2009; Cai and Liu, 2012; Fan et al., 2012; Mai et al., 2012; Fan
et al., 2013; Han et al., 2013; Dicker and Zhao, 2016).
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2.3 Integrative classification via Bayesian modeling
It is not obvious how to properly incorporate the auxiliary summary statistics Tj into an
integrative classifier. The form of the optimal classifier δ? (2) gives no indication as to how
the Tj can be used, yet it is intuitively clear that the parameters λj underlying the Tj can
contain information about the piyj and should be leveraged. The λj can be viewed as latent
annotation information for each SNP. If the target disease is truly related to the auxiliary
disease, a large value of λj provides additional evidence that the jth SNP may be useful for
predicting Ynew, even if the effect size of that SNP in the target disease training data D is
weak.
Properly leveraging the Tj to improve prediction of the target disease poses several
methodological challenges. First, the λj are not directly observed. Second, how they should
be used depends on the extent of the genetic similarity between the target and auxiliary
diseases. For example, some SNPs may be predictive only of the auxiliary disease but not
of the target disease, or vice versa, so just because a SNP has a large λj in the auxiliary
GWAS does not necessarily mean that it is useful for predicting the target disease. It is not
clear how best to leverage the λj in this case. Finally, it may not always be known whether
genetic correlations exist, for example if the diseases are poorly understood.
This paper proposes a new method that can address each of these challenges. The method
is motivated by a Bayesian model for the (Xnew, Ynew), D, and T, which assumes that
(pi0j, pi1j, λj) ∼ G (3)
for some trivariate prior distribution G. Under this assumption, (Xnew, Ynew), D, and T
are no longer necessarily mutually independent, and the misclassification rate R(δ) (1) is be
minimized by the classifier
I
{
− log P
1− P ≤
d∑
j=1
log
∫
fBin(Xnew,j; 2, u1)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)dG(u0, u1, l)∫
fBin(Xnew,j; 2, u0)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)dG(u0, u1, l)
}
,
(4)
where Syj =
∑
i:Yi=y
Xij and fχ2(x; ν, λ) is the probability density function of a χ
2
ν(λ) distri-
bution. To derive (4) it is also assumed that the (pi0j, pi1j, λj) and the Yi, i = new, 1, . . . , n are
independent, which is reasonable because the parameter values can be thought of as being
drawn from G independently of the cases and controls being drawn from the population of
subjects.
The form of (4) is the key to the proposed approach. Unlike the optimal classifier δ? (2),
in which neither T nor D appear, (4) provides a sensible way for integrating the Tj with the
D. In fact, if the Bayesian assumption (3) is true, (4) is the optimal method of integrating
Tj and D. Even under the present frequentist setting described in Section 2.1, procedures
motivated by Bayesian formalisms can still have excellent performance, for example in fre-
quentist compound decision problems (Robbins, 1951; Robbins et al., 1951; Zhang, 2003;
Brown and Greenshtein, 2009; Jiang et al., 2009; Gu and Koenker, 2015a).
The prior G implicitly encodes the additional information about (pi0j, pi1j) that can be
borrowed from the auxiliary study, via the correlation between the minor allele frequencies
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and the latent annotations λj. In the extreme case where the target and auxiliary diseases are
not genetically correlated, G factors into the product of a bivariate distribution on (pi0j, pi1j)
and a univariate distribution on λj. The terms involving Tj will then cancel out in (4),
resulting in a non-integrative classifier that depends only on the target training data.
2.4 Nonparametric empirical Bayes classification using latent an-
notations
The integrals in (4) must be estimated, because the prior G is unknown. One possibility is to
assume that G lies in a parametric family. However, G is a complex multivariate distribution
and it is not clear what family can be used. An attractive alternative is the nonparametric
maximum likelihood estimator of Kiefer and Wolfowitz (1956), which in the present context
takes the form
Gˆ = arg max
G∈G
d∏
j=1
∫
fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)dG(u0, u1, l), (5)
where G is the set of all trivariate distributions. The advantage of Gˆ is that it requires
minimal assumptions, no tuning parameters, and is a consistent estimator of the true mixing
distribution G (Kiefer and Wolfowitz, 1956). More importantly, it uses the observed data to
automatically learn the degree to which the target and auxiliary diseases are related.
The proposed classifier is obtained by replacing G in the Bayesian classifier (4) with the
estimate Gˆ. This will be referred to as a nonparametric empirical Bayes classifier using
latent annotations, or NEBULA. It is clear from (4) and (5) that NEBULA can be trained
using only summary statistics Tj from the auxiliary GWAS and Syj from the target disease
training data. This is a major advantage over existing integrative classifiers. NEBULA can
also incorporate additional non-genetic predictors such as age or gender. Denote these by
Znew,j, j = 1, . . . , q and let fj(z;θyj) be the density of the jth predictor in class y ∈ {0, 1},
where θyj is a vector of parameters. Let θˆyj be the maximum likelihood estimates of θyj
obtained from training data Zij, i = 1, . . . , n. With these additional covariates, NEBULA is
defined as
δˆNEBULA(Xnew;D,T) = I
{
− log P
1− P ≤
q∑
j=1
log
fj(Znew,j; θˆ1)
fj(Znew,j; θˆ0)
+
d∑
j=1
log
∫
fBin(Xnew,j; 2, u1)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)dGˆ(u0, u1, l)∫
fBin(Xnew,j; 2, u0)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)dGˆ(u0, u1, l)
}
.
(6)
NEBULA is designed to directly predict the class Ynew of the newly observed genotype vector
Xnew, but the sum inside the indicator function in (6) can also be treated as a continuous
score for the newly observed subject. This score can then be used to calculate area under
the curve statistics or can be calibrated to provide a risk score (Cook, 2007).
The accuracy of NEBULA is determined in part by the sample sizes of the target and
auxiliary studies. Larger sample sizes reduce the signal-to-noise ratios of the S0j, S1j, and
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Tj. For example, for y ∈ {0, 1}, the inverse coefficient of variation of the binomial random
variable Syj is (nypi
1/2
yj )/{nypiyj(1 − piyj)}−1/2, which increases with the square root of the
target study sample size. Similarly, the inverse of the coefficient of variation of the noncentral
chi-square Tj is (1 + λj)/{2(k + 2λj)}1/2. Since SNPs that are associated with the auxiliary
disease have noncentrality parameters λj that are directly proportional to the sample size of
the auxiliary study, this quantity increases with the square root of the auxiliary sample size.
These smaller signal-to-noise ratios make the deconvolution problem less difficult and thus
allow for better estimate of the integrals in (4).
2.5 Implementation
The Kiefer-Wolfowitz estimator Gˆ (5) is difficult to calculate. To mitigate the computational
burden, Koenker and Mizera (2014) recently proposed a finite-dimensional approximation
to Gˆ. For y ∈ {0, 1} let Πy be a set of dy equally-spaced grid points minj pˆiyj = uy1 <
. . . < uydy = maxj pˆiyj, where pˆiyj = Syj/(2ny) is the maximum likelihood estimate of piyj.
Similarly, let Λ be a set of d2 equally-spaced grid points minj Tj = l1 < . . . < ld2 = maxj Tj.
The Koenker-Mizera approximation is identical to (5) except that the optimization is not over
the class of all trivariate distributions, but instead over all discrete trivariate distributions
supported on Π0 × Π1 × Λ. The resulting estimator is the solution to a discrete convex
optimization problem and can be conveniently computed (Feng and Dicker, 2016).
Though the Koenker-Mizera estimator is an approximation to the true nonparametric
maximum likelihood estimator Gˆ, it has been shown to work extremely well in many prob-
lem (Koenker and Gu, 2014; Koenker, 2014; Gu and Koenker, 2015b; Dicker and Zhao, 2016;
Feng and Dicker, 2016; Jiang and Zhang, 2016). Ideally the number of points d0, d1, and d2
used to construct the grids Π0, Π1, and Λ should be as large as possible given constraints
on computation time and memory, but in practice relatively few are needed for good perfor-
mance. A theoretical characterization of a sufficient number of grid points is given by Dicker
and Zhao (2016).
Koenker-Mizera estimators for various problems are calculated using fast interior point
methods in the R package REBayes (Koenker, 2013; Koenker et al., 2014). However, for
the trivariate problem (5) considered in this paper, REBayes does not contain a ready-made
implementation. The expectation-maximization algorithm offers a simple alternative (Feng
and Dicker, 2016). Specifically, let dGk(u0, u1, l) be the mass corresponding to the grid point
(u0, u1, l) ∈ Π0 × Π1 × Λ at the kth iteration of the algorithm. Then the k + 1th update is
dGk+1(u0, u1, l) =
1
d
d∑
j=1
dGk(u0, u1, l)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)∑
(u0,u1,l)∈Π0×Π1×Λ dG
k(u0, u1, l)fBin(S0j; 2n0, u0)fBin(S1j; 2n1, u1)fχ2(Tj; 1, l)
.
(7)
This implementation has been made available in the R package ssa.
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3 Results
3.1 Methods compared
In order to provide a performance baseline against which NEBULA (6) can be judged, the
standard non-integrative polygenic risk score (PRS) classifier (Purcell et al., 2009; Shi and
Lee, 2016) was implemented. Let P be the prevalence of the target disease in the population.
In practice P is often known from previous epidemiological studies, or in cohort sampling
designs can be estimated from the training data. The PRS classifier is then defined as
δPRS(Xnew;D) = I
{
2
d∑
j=1
log
1− pˆi1j
1− pˆi0j +
d∑
j=1
βˆjI(|βˆj| > λ)Xnew,j ≥ − log P
1− P
}
, (8)
where
βˆj = log
pˆi1j/(1− pˆi1j)
pˆi0j/(1− pˆi0j)
is the maximum likelihood estimate of the log-odds ratio based on the training data D.
The parameter λ is a threshold that serves to remove unimportant SNPs from the classifier.
The PRS is nearly identical to the oracle classifier δ? (2) after plugging in the maximum
likelihood estimates of the piyj, except for the thresholding step. The optimal value of λ can
be determined using cross-validation.
In addition to NEBULA, two new alternative integrative genetic risk prediction algo-
rithms were implemented for comparison. Neither of these has been yet been described in
the literature and may be interesting in their own rights. Let γˆj denote the log-odds ratio of
the jth SNP estimated from the auxiliary GWAS data. SNPs with larger Tj will also have
γˆj with larger magnitudes. The new classifiers are:
1. An adaptive version of the PRS: SNPs with |βˆj γˆj| ≤ λ are dropped; the remaining
ones are still weighted by βˆj in the PRS. This allows SNPs with relatively weak |βˆj| to
still be included in the prediction algorithm as long as |γˆj| is sufficiently large.
2. Adaptive lasso (Zou, 2006): logistic lasso regression (Tibshirani, 1996) is implemented
using the γˆj as adaptive weights:
βˆ = arg min
β
{
−`(β) + λ
d∑
j=
|βj|
|γˆj|
}
,
where β = (β1, . . . , βd)
> is the regression coefficient, `(β) is logistic log-likelihood of
the training data D, and λ is a tuning parameter selected using cross-validation. This
has the same effect as the adaptive PRS.
A potential problem with these alternative methods is that they implicitly assume that the
SNPs that are significant in the auxiliary data are the same as those that are predictive of
the target disease. When this is indeed true, or approximately true, these methods should
perform well, but heterogeneity between the genetic etiologies of the target and auxiliary
diseases may cause these methods to have low prediction accuracy.
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3.2 Simulation studies
To simulate genotype data for the target disease of interest, the total number of SNPs
was d = 10, 000 in all simulations. Some SNPs were set to be associated with the target
disease; the number of these non-null SNPs was varied across simulation settings. In controls,
the minor allele frequencies pi0j were randomly generated uniformly in [0.2, 0.5]. In cases,
the minor allele frequencies for null SNPs were set equal to the corresponding pi0j. For
non-null SNPs, log-odds ratios βj were first generated from N(µ, 0.01) and then randomly
multiplied by 1 or −1. The value of µ was varied across simulation settings. The minor allele
frequencies were then set to pi1j = expit{βj + logit(pi0j)}, where expit(x) is the inverse of the
logit(x) = log{x/(1−x)}. Once generated, the pi0j and pi1j were fixed across all replications.
Finally, to generate the training data D, n0 = n1 = 100 control and case genotype vectors
were generated with Xij ∼ Bin(2, pi0j) and Xij ∼ Bin(2, pi1j), respectively. To generate the
testing data, n0 = n1 = 50 controls and cases were generated in the same way. A prevalence
of P = 1/2 was used when implementing all classifiers.
Genotype data for the auxiliary disease were simulated in the same fashion, but with
different sample sizes. The number of SNPs associated with the auxiliary disease was also
varied across simulation settings. The percent overlap between the SNPs that were non-null
for the auxiliary disease and those that were non-null for the target disease was varied as
well, representing different degrees of genetic heterogeneity between the diseases. When the
two sets of non-null SNPs had different sizes, the percentage is understood to be relative to
the smaller set. Estimated log-odds ratios γˆj and chi-square test statistics Tj from allelic
tests of association were calculated from the auxiliary data. Only these summary statistics,
and not the raw data, were used by the integrative algorithms described in Section 3.1.
The Koenker-Mizera estimator (7) used in the NEBULA classifier was implemented using
20 equally-spaced points to construct the grids Πy, y ∈ {0, 1} and Λ.
Figure 1 reports the average misclassification rates across 200 replications of each simula-
tion setting when the auxiliary data were generated with n0 = n1 = 1, 000 controls and cases.
All three integrative classifiers had improved accuracy as the percentage overlap of non-null
SNPs increased. This confirms that each method was indeed able to utilize information from
the auxiliary summary statistics.
Figure 2 illustrates the impact of generating 250, 500, and 1,000 cases and controls in
the auxiliary data. As discussed in Section 2.4, larger sample sizes allow for more accurate
estimation of the integrals in (4). Not surprisingly, misclassification errors decreased as the
size of the auxiliary study increased for all three integrative classifiers.
NEBULA outperformed the other integrative classifiers when the target and auxiliary dis-
eases were more genetically heterogeneous. When the overlap between the target-significant
SNPs and the auxiliary-significant SNPs was only 25%, NEBULA had the lowest misclassi-
fication rates in most of the simulation settings. As discussed in Section 3.1, the adaptive
PRS and lasso methods should have difficulty in this situation. In contrast, NEBULA au-
tomatically learns the true degree of similarity between the target disease and the auxiliary
summary statistics, via the nonparametric maximum likelihood estimator (5), and can ignore
the auxiliary data if the similarity is not strong. Furthermore, Figure 1 shows that NEBULA
can outperform the baseline non-integrative PRS even when the target and auxiliary dis-
eases are quite genetically different, while the misclassification rates of the other integrative
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Figure 1: Average misclassification rates when the auxiliary data were generated with n0 =
n1 = 1, 000 controls and cases.
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Figure 2: Average misclassification rates for different auxiliary study sample sizes
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Table 1: Pediatric autoimmune disorders studied by Hakonarson and colleagues.
Disorder Abbreviation
Ankylosing spondylitis AS
Common variable immunodeficiency disorder CVID
Crohn’s disease CD
Celiac’s disease CEL
Juvenile idiopathic arthritis JIA
Psoriasis PS
Systemic lupus erythematosus SLE
Thyroiditis THY
Type I diabetes T1D
Ulcerative colitis UC
classifiers could be much higher than baseline. This is important because in practice the
degree of similarity between the target and auxiliary diseases may be unknown, especially
for poorly understood diseases.
These simulation results also indicate that the relative improvement of NEBULA over
the other integrative classifiers was highest when there were more predictive SNPs in the
target study. This is because the soft thresholding in the adaptive PRS and adaptive lasso
algorithms make them better suited to sparse settings, where there are a small number of
important predictors with relatively strong effect sizes. In contrast, NEBULA does not
threshold any predictors and instead aggregates information from every SNP. It is thus
more suited for dense settings, where there are a large number of important predictors with
relatively weak effect sizes. This type of dense configuration may be especially relevant
in genetic risk prediction, as it has been hypothesized to be one of the causes of missing
heritability (Manolio et al., 2009; Chatterjee et al., 2013; Dudbridge, 2013).
3.3 Application to pediatric autoimmune disease
Hakonarson and colleagues at the Children’s Hospital of Pennsylvania (Li et al., 2015a,b)
collected genotype data for ten different pediatric autoimmune disorders from more than
5,000 cases and 10,000 shared age- and gender-matched controls of European ancestry; see
Table 1. The numbers of cases per disorder were relatively small, ranging from 100 to 2,000,
so training genetic risk prediction models is difficult. In this section, the proposed NEBULA
classifier (6) and the alternative methods described in Section 3.1 are applied to this pediatric
autoimmune data.
To apply the integrative classifiers, each of the ten autoimmune disorders was treated in
turn as the target disease for genetic risk prediction, and each of the remaining nine disorders
was in turn used as the auxiliary disease. Some pediatric autoimmune diseases have been
found to be genetically correlated (Li et al., 2015a,b), so it is reasonable to integrate results
from one disorder to help predict another. For each target disease, training data consisted
of 90% of the available target disease samples and the same number of subjects from the
control data, all randomly selected. The other 10% of the target disease samples and an
equal number of random control subjects comprised the testing data. The remaining control
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Table 2: Auxiliary GWAS from the EGG Consortium.
Trait Abbreviation Sample size Reference
Birth length BL 28,459 van der Valk et al. (2015)
Birth weight BW 26,836 Horikoshi et al. (2013)
Childhood BMI BMI 35,668 Felix et al. (2016)
Childhood obesity OB 13,848 Bradfield et al. (2012)
subjects were combined with the data for the auxiliary disease in order to calculate log-
odds ratios γˆj and summary statistics Tj. This sample splitting procedure was repeated
50 times and the misclassification errors of the different classifiers were averaged across the
replications.
In addition to the autoimmune disorder data, additional auxiliary GWAS summary re-
sults were obtained from the Early Growth Genetics (EGG) Consortium; see Table 2. The
EGG Consortium conducts large GWAS meta-analyses of traits related to childhood growth
in humans. It is reasonable to suspect that some of the loci that cause pediatric autoimmune
disorders may also affect the early growth traits listed in Table 2. Integrative classifiers were
applied to leverage the large sample sizes in the EGG studies to potentially improve the
accuracy of predicting autoimmune disease risks.
Subjects were genotyped using Illumina HumanHap550 and Human610 BeadChip arrays,
and only variants on autosomal chromosomes typed on both platforms were considered in
this analysis. Similar to Shi and Lee (2016), SNPs were pruned using the --indep-pairwise
tool in the software PLINK (Purcell et al., 2007) such that no SNPs within a 50 base pair
window had r2 > 0.01. Pruning was performed using reference CEU genotype data from
release 23 of the HapMap Project (Gibbs et al., 2003) and left 9,491 SNPs. In each of the
datasets in Table 1, missing genotypes were then imputed by estimating the minor allele
frequency of the corresponding SNP and then using the estimate to randomly generate
genotypes assuming Hardy-Weinberg equilibrium. More sophisticated imputation strategies
can also be employed. Before applying the classifiers, SNPs with minor allele frequencies
below 1% and/or found not to be in Hardy-Weinberg equilibrium at a p-value threshold of
10−3 were dropped from analysis.
Each classifier described in Section 3.1 was applied to all 130 possible target-auxiliary
disease pairs. Gender was always included as a predictor. It was incorporated into PRS,
adaptive PRS, and NEBULA using the method described in (6) in Section 2.4, and it was
not penalized in adaptive PRS or adaptive lasso. The Koenker-Mizera estimator (7) used
in NEBULA was implemented using 40 equally-spaced points to construct the grids Πy, y ∈
{0, 1} and Λ.
The average misclassification rates over the 50 replications are plotted in Figure 3. They
show that integrative classification can indeed be effective in improving prediction perfor-
mance relative to the baseline PRS classifier. The most striking examples occur with Crohn’s
disease (CD) as the target and thyroiditis (THY) as the auxiliary, and with THY as the tar-
get and CD the auxiliary. For these pairs all three integrative methods have substantially
lower misclassification rates than non-integrative PRS.
Figure 3 also shows that the proposed NEBULA classifier can outperform the other two
integrative procedures. For example, when predicting common variable immunodeficiency
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Figure 3: Average misclassification rates for target pediatric autoimmune diseases, using
other autoimmune disease and EGG consortium GWAS results as auxiliary data. See Ta-
bles 1 and 2 for abbreviation definitions.
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disorder (CVID) and psoriasis (PS), NEBULA had the lowest misclassification errors among
all classifiers for all auxiliary diseases. Of particular interest are the results of using the
EGG Consortium’s childhood birth length (BL) GWAS summary statistics as auxiliary data
to predict PS. Here, NEBULA outperformed adaptive PRS, and adaptive lasso and gave a
nearly 10% improvement in prediction performance relative to non-integrative PRS.
When predicting systematic lupus erythematosus (SLE), NEBULA was outperformed
by the other integrative classifiers. It turns out that SLE can be very accurately predicted
using gender alone as a single predictor. This corresponds to the sparse predictor setting,
and as discussed in the simulations in Section 3.2, it is not unexpected that adaptive PRS
and adaptive lasso can outperform NEBULA when important predictors are very sparse.
On the other hand, as mentioned in Sections 3.1 and 3.2, a disadvantage of adaptive PRS
and adaptive lasso is that they can sometimes perform much worse than the baseline non-
integrative PRS when the target and auxiliary diseases are highly genetically heterogeneous.
This phenomenon was observed when predicting many of the disorders, such as THY, juvenile
idiopathic arthritis (JIA), PS, and T1D. In contrast, NEBULA was never much worse than
baseline in any of the analyses.
4 Discussion
This paper has so far discussed the integration of auxiliary GWAS summary statistics Tj
to improve genetic risk prediction, as the Tj provide latent annotation information for each
SNP. However, in some cases important annotations are directly observed, for example if
the SNP lies in a DNase I hypersensitive site. It is simple to extend NEBULA (6) to
accommodate directly observed annotations. Let Ij ∈ {0, 1} annotate the jth SNP. Then
the prior assumption (3) on minor allele frequencies piyj, y ∈ {0, 1} becomes (pi0j, pi1j) |
Ij = 0 ∼ G0 and (pi0j, pi1j) | Ij = 1 ∼ G1. The Gy, y ∈ {0, 1} can again be estimated
nonparametrically, and a classifier similar to NEBULA can be derived. The advantage of
this formulation is that it does not require perfect concordance between the SNPs predictive
of the target disease and those with Ij = 1. Furthermore, it is also simple modify NEBULA
to simultaneously integrate both Tj and Ij. These extended classifiers are implemented in
the R package ssa.
In principle the NEBULA framework can be applied to multiple sources of auxiliary sum-
mary statistics T kj , k = 1, . . . , K. This would necessitate a multivariate prior distribution
on (pi0j, pi1j, T
1
j , . . . , T
K
j ), from which the corresponding Bayesian classifier can be derived.
However, nonparametric estimation of this multivariate prior will be both theoretically and
computationally challenging. A possible solution is to develop convenient closed-form esti-
mators, which may not be optimally adaptive to the true prior G but may still have good
performance. This is an interesting direction of future research.
Even in the present case, nonparametric estimation of a trivariate prior distribution is
computationally challenging. Faster strategies would make feasible genetic risk prediction
using genome-wide SNP data without LD pruning. One approach would be to limit the
support of the estimated prior. For example, the Koenker-Mizera estimator described in
Section 2.5 supports the (pi0j, pi1j) on the grid Π0×Π1. However, most SNPs frequencies are
likely to be similar between cases and controls, such that pi0j ≈ pi1j for most j. Thus most
15
grid points in Π0×Π1 should have zero mass. Enforcing this can reduce the number of grid
points and speed up estimation of the prior G. Further work in this direction is necessary.
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